New San Diego VC Firm Emerges as ‘The Moneyball of Venture Capital’ | Xconomy
www.xconomy.com
JUNE 9, 2012
Tech Channels ▾ Cleantech ›. Coats says the VC firm spent more than six years and invested millions of dollars to compile a database of key variables from more than 60,000 venture financing deals covering roughly 98 percent of all U.S. FDA Clears New Genentech Breast Cancer Drug, in Combo With Herceptin. View More in Seattle ›.
Let's personalize your content